|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flow from operating activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash flow provided by operating activities: | ||
| Depreciation and amortization | ||
| Amortization and write-off of debt issuance costs | ||
| Stock -based compensation | ||
| Gain on disposition of real estate | ||
| Assumption of buildings due to ground lease terminations | ||
| Net change in accounts receivable | ||
| Net change in accounts payable and accrued expenses | ||
| Net change in other operating assets and liabilities | ||
| Total adjustments | ||
| Net cash flow provided by operating activities | ||
| Cash flow from investing activities: | ||
| Real estate acquired, net of liabilities and cash assumed | ||
| Deposits for future acquisitions | ||
| Real estate improvements to operating real estate | ||
| Proceeds from disposition of real estate | ||
| Net cash flow used for investing activities | ||
| Cash flow from financing activities: | ||
| Proceeds from term loan | ||
| Proceeds from unsecured notes | ||
| Repayment of mortgage debt | ||
| Payment of debt issuance costs | ||
| Common stock offering expenses | ||
| Taxes withheld for vested restricted stock | ||
| Purchase of common stock in conjunction with equity award plans | ||
| Acquisition of non-controlling interests | ||
| Transactions with Parent | ||
| Dividends paid | ||
| Net cash flow provided by financing activities | ||
| Net (decrease) increase in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash, beginning of period | ||
| Cash, cash equivalents and restricted cash, end of period |
Loading...
